See also this year's filing and all EDGAR filings for this company.
PDF Report 0001615219_2022_Salarius_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001615219, Salarius Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 30,163,595 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 8,865,909 |
| 2 | PropertyPlantAndEquipmentNet | 7,880 |
| 3 | remainder_Assets | 1,796,484 |
| 4 | LiabilitiesCurrent | 1,543,096 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 567,787 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 6,104,627 |
| 9 | ResearchAndDevelopmentExpense | 8,548,520 |
| 10 | remainder_Expenses | -44,693 |
| 11 | remainder_Revenues | 1,840,216 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 40,833,868 |
| 1 | Liabilities | 2,110,883 |
| 2 | Expenses | 14,608,454 |
| 3 | Revenues | 1,840,216 |
| 4 | StockholdersEquity | 38,722,985 |
| 5 | NetIncome | -12,768,238 |
| 6 | ComprehensiveNetIncome | -12,768,238 |
| 7 | BaseVar | 29,696,710 |
| 8 | EconomicCapitalRatio | 2.51 |